Personalized therapies combine with the precision medicine has made it possible to improve patient treatment decisions based on individual, genetic, lifestyle and environmental backgrounds. ‘Precision medicine’ and ‘personalised medicine’ are new area of healthcare where personalising treatment is based on the individual patient's inherited traits and characteristics, and how those traits and characteristics helps the patient to react to different kinds of treatments and therapies. For example, genomics, epigenomics, transcriptomics, proteomics and metabolomics data has been used to develop targeted therapies for cancers, autoimmune diseases, and genetic abnormalities.
Emerging new technologies like next-gen sequencing, bioinformatics, and AI have made precision medicine and personalized treatments possible. These let us find new biomarkers, make targeted therapies, and optimize treatments for specific patients. But putting precision medicine into practice is relatively difficult. We need huge datasets to analyse. And we must consider regulations and ethics too. Personalized therapies on the contrary utilize this data to provide targeted treatments that are best suited to an individual patient's needs. This increases the success outcomes thereby decreasing side effects and cutting medical bills.